BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 27404349)

  • 1. Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamide.
    Pett L; Kiakos K; Satam V; Patil P; Laughlin-Toth S; Gregory M; Bowerman M; Olson K; Savagian M; Lee M; Lee M; Wilson WD; Hochhauser D; Hartley JA
    Biochim Biophys Acta Gene Regul Mech; 2017 May; 1860(5):617-629. PubMed ID: 27750031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients.
    Ferrandina G; Petrillo M; Carbone A; Zannoni G; Martinelli E; Prisco M; Pignata S; Breda E; Savarese A; Scambia G
    Br J Cancer; 2008 Jun; 98(12):1910-5. PubMed ID: 18506140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase IIα immunoexpression in feline mammary carcinomas: A correlation with Ki67 immunoexpression and the mitotic count.
    Łopuszyński W; Brzana A; Szczubiał M; Bulak K; Śmiech A
    Res Vet Sci; 2023 Nov; 164():104992. PubMed ID: 37657395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localisation of DNA topoisomerase IIalpha in mouse erythroleukemia cells.
    Ivanova EC; Donev RM; Djondjurov LP
    Mol Cells; 1999 Jun; 9(3):309-13. PubMed ID: 10420991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of SUMOylation of topoisomerase IIalpha with Xenopus egg extracts.
    Azuma Y
    Methods Mol Biol; 2009; 582():221-31. PubMed ID: 19763953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of DNA Supercoil Handedness during Catenation Catalyzed by Type II Topoisomerases.
    Dalvie ED; Stacy JC; Neuman KC; Osheroff N
    Biochemistry; 2022 Oct; 61(19):2148-2158. PubMed ID: 36122251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications.
    Soliman TN; Keifenheim D; Parker PJ; Clarke DJ
    J Cell Biol; 2023 Dec; 222(12):. PubMed ID: 37955972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different susceptibilities of postmitotic checkpoint-proficient and -deficient Balb / 3T3 cells to ICRF-193, a catalytic inhibitor of DNA topoisomerase II.
    Nishida K; Seto M; Ishida R
    Jpn J Cancer Res; 2001 Feb; 92(2):193-202. PubMed ID: 11223549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for allosteric regulation of Human Topoisomerase IIα.
    Vanden Broeck A; Lotz C; Drillien R; Haas L; Bedez C; Lamour V
    Nat Commun; 2021 May; 12(1):2962. PubMed ID: 34016969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narciclasine, a novel topoisomerase I inhibitor, exhibited potent anti-cancer activity against cancer cells.
    Wang M; Liang L; Wang R; Jia S; Xu C; Wang Y; Luo M; Lin Q; Yang M; Zhou H; Liu D; Qing C
    Nat Prod Bioprospect; 2023 Aug; 13(1):27. PubMed ID: 37640882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic tagging reveals a random association of endogenous PtdIns5P 4-kinases IIalpha and IIbeta and a partial nuclear localization of the IIalpha isoform.
    Wang M; Bond NJ; Letcher AJ; Richardson JP; Lilley KS; Irvine RF; Clarke JH
    Biochem J; 2010 Sep; 430(2):215-21. PubMed ID: 20569199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of active AKT in the nucleus upon adipocyte differentiation of 3T3-L1 cells.
    Goris M; Jacobsen RG; Lewis AE
    MicroPubl Biol; 2024; 2024():. PubMed ID: 38495585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal and spatial distribution of DNA topoisomerase II alters during proliferation, differentiation, and apoptosis in HL-60 cells.
    Sugimoto K; Yamada K; Egashira M; Yazaki Y; Hirai H; Kikuchi A; Oshimi K
    Blood; 1998 Feb; 91(4):1407-17. PubMed ID: 9454772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of proteasomal degradation in the cell cycle-dependent regulation of DNA topoisomerase IIalpha expression.
    Salmena L; Lam V; McPherson JP; Goldenberg GJ
    Biochem Pharmacol; 2001 Apr; 61(7):795-802. PubMed ID: 11274964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome profiling of mitotic clonal expansion during 3T3-L1 adipocyte differentiation using iTRAQ-2DLC-MS/MS.
    Jiang Y; Guo L; Xie LQ; Zhang YY; Liu XH; Zhang Y; Zhu H; Yang PY; Lu HJ; Tang QQ
    J Proteome Res; 2014 Mar; 13(3):1307-14. PubMed ID: 24450392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Roles of DNA Topoisomerase IIβ in Transcription.
    Madabhushi R
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical resistance to topoisomerase-targeted drugs.
    Dingemans AM; Pinedo HM; Giaccone G
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):275-88. PubMed ID: 9748627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Topoisomerase IIα contributes to the early steps of adipogenesis in 3T3-L1 cells.
    Jacobsen RG; Mazloumi Gavgani F; Mellgren G; Lewis AE
    Cell Signal; 2016 Oct; 28(10):1593-603. PubMed ID: 27404349
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.